Alabama
Aniston; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Aniston; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Aniston; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Aniston; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Aniston; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Aniston; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Birmingham; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Birmingham; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Birmingham; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Birmingham; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Birmingham; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Birmingham; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Birmingham; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Birmingham; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Birmingham; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Birmingham; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Birmingham; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Birmingham; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Birmingham; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Huntsville; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Huntsville; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Huntsville; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Huntsville; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Huntsville; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Huntsville; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Huntsville; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Montgomery; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Montgomery; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Montgomery; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Montgomery; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Montgomery; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Tuscaloosa; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Tuscaloosa; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Tuscaloosa; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Tuscaloosa; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Various Cities; Research Center
Rheumatoid Arthritis Study CAIN457A2101
Arizona
Hot Springs; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Lake Havasu City; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Paradise Valley; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Paradise Valley; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Paradise Valley; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Paradise Valley; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Paradise Valley; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Paradise Valley; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Paradise Valley; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Paradise Valley; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Paradise Valley; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Paradise Valley; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Paradise Valley; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Peoria; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Peoria; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Peoria; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Peoria; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Peoria; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Peoria; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Peoria; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Peoria; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Peoria; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Peoria; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Phoenix; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Phoenix; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Phoenix; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Phoenix; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Phoenix; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Phoenix; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Phoenix; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Phoenix; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Phoenix; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Phoenix; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Phoenix; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Phoenix; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Scottsdale; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Scottsdale; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Scottsdale; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Scottsdale; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Scottsdale; Research Site:
A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.
Scottsdale; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Scottsdale; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Scottsdale; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Tucson; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Tucson ; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Tucson; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Tucson ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Tucson ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Tucson ; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Tucson ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Tucson ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Tucson ; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Tucson ; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Tucson ; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Tucson ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Tucson ; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Tucson ; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Tucson ; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Arkansas
Hot Springs; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Hot Springs; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Jonesboro; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Jonesboro; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Jonesboro; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Little Rock; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Little Rock; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Little Rock; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Little Rock; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Little Rock; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Little Rock; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Little Rock; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Little Rock; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Little Rock; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Little Rock; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Little Rock; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Little Rock; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Little Rock; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Little Rock; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Little Rock; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
California
Anaheim; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Anaheim; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Beverly Hills; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Beverly Hills; Impact Clinical Trials
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Escondido; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Escondido; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Escondido; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Fair Oaks; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Fountain Valley; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Fullerton; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Fullerton; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Fullerton; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Huntington Beach; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Huntington Beach; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
La Jolla; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
La Jolla; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
La Jolla; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
La Jolla; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
La Jolla; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Loma Linda; DHARMA Health and Research Management
Pain Study
Loma Linda; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Long Beach; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Long Beach; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Long Beach; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Long Beach; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Long Beach; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Long Beach; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Long Beach; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Long Beach; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Long Beach; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Long Beach; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Long Beach; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Los Angeles; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Los Angeles; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Los Angeles; UCLA Medical Center
Responses to Stress/Pain in Parents and Children Study
Los Angeles; UCLA Medical Center
Iyengar Yoga for Young Adults with Rheumatoid Arthritis
Los Angeles; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Los Angeles; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Los Angeles; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Los Angeles; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Los Angeles; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Los Angeles; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Los Angeles; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Los Angeles; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Los Angeles; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Los Angeles; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Los Angeles; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Los Angeles; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Northridge; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Palm Desert; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Palm Desert; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Palm Desert; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Palm Desert; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Palm Desert; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Palm Desert; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Palm Desert; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Palm Springs; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Palm Springs; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Palo Alto; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Palo Alto; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Palo Alto; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Palo Alto; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Palo Alto; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Pasadena; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Pasadena; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Pasadena; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Pasadena; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Pasadena; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Rancho Mirage; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Rancho Mirage; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Rancho Mirage; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Riverside; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Sacramento; Sutter Institute for Medical Research (SIMR)
Rheumatoid Arthritis - Male and Female participants
Sacramento; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Sacramento; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
San Diego ; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
San Diego ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
San Diego ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
San Diego ; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
San Diego ; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
San Diego ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
San Diego ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
San Diego ; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
San Diego ; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
San Diego ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
San Diego ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
San Francisco; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
San Jose; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
San Jose; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
San Jose; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
San Leandro; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
San Leandro; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
San Leandro; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
San Leandro; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
San Leandro; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
San Luis Obispo; Coastal Medical Research Group, Inc.
Have you been diagnosed with Oseoarthritis or Rheumatoid Arthritis?
Santa Barbara; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Santa Maria; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Santa Maria; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Santa Maria; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Santa Maria; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Santa Maria; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Santa Maria; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Santa Maria; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Santa Maria; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Santa Maria; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Santa Monica; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Santa Monica; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Torrance ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Torrance ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Torrance ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Tustin; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Tustin; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Upland; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Upland; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Upland; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Upland; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Upland; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Upland; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Upland; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Upland; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Upland; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Van Nuys; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Walnut Creek; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Whittier; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Whittier; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Whittier; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Colorado
Aurora; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Aurora; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Aurora; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Aurora; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Aurora; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Boulder; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Colorado Springs; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Colorado Springs; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Colorado Springs; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Colorado Springs; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Colorado Springs; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Colorado Springs; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Colorado Springs; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Colorado Springs; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Colorado Springs; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Colorado Springs; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Denver; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Denver; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Denver; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Connecticut
Bridgeport; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Bridgeport; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Camden; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Danbury; Clinical Research Center of CT
Do you have Rheumatoid Arthritis
Danbury; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Danbury; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Danbury; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Hamden; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Hamden; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Stamford; Stamford Therapeutics Consortium
Rheumatoid Arthritis pain?
Stamford; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Trumball; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Trumball; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Trumbull; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Trumbull; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Trumbull; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Trumbull; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Waterbury; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Delaware
Lewes; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Lewes; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Lewes; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Newark; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Newark; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Newark; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Newark; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Newark; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Newark; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Newark; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Florida
Aventura; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Aventura; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Aventura; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Aventura; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Aventura; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Aventura; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Aventura; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Aventura; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Aventura; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Aventura; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Aventura; South Florida Medical Research
Phase IV, Double-Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen.
Aventura; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Boca Raton; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Boca Raton; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Boca Raton; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Boca Raton; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Boca Raton; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Boca Raton; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Boca Raton; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Boca Raton; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Clearwater; Clinical Research of West Florida, Inc.
Volunteers Needed
Clearwater; Clinical Research of West Florida, Inc.
Volunteers Needed
Clearwater; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Clearwater; Clinical Research of West Florida
Bothered by Arthritis? Concerned About Heart Disease?
Delray Beach; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Delray Beach; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Delray Beach; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Delray Beach; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Delray Beach; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Delray Beach; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Dunedin; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Dunedin; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Fort Lauderdale; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Fort Lauderdale; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Fort Lauderdale; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Fort Lauderdale; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Fort Lauderdale; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Fort Lauderdale; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Fort Lauderdale; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Fort Lauderdale; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Fort Lauderdale; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Gainesville; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Gainesville; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Gainesville; Florida Medical Research Institute
RHEUMATOID ARTHRITIS ?
Gainesville; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Jacksonville; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Jacksonville; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Jacksonville; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Jacksonville; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Jacksonville; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Jupiter; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Jupiter; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Jupiter; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Jupiter; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Jupiter; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Jupiter; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Jupiter; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Lake Mary; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Largo; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Largo; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Largo; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Largo; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Largo; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Longwood; Genesis Research International
Bothered by arthritis? Concerned about heart disease?
Melbourne; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Miami; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Ocala; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Orange Park; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Orlando; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Orlando; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Orlando; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Orlando; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Orlando; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Orlando; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Orlando; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Orlando; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Orlando; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Orlando; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Ormond Beach; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Palm Harbor; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Palm Harbor; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Palm Harbor; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Palm Harbor; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Palm Harbor; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Palm Harbor; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Palm Harbor; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Palm Harbor; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Palm Harbor; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Palm Harbor; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Palm Harbor; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Palm Harbor; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Pinellas Park; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Plantation; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Port Orange; Coastal Medical Research, Inc
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Sarasota; Lovelace Scientific Resources - Sarasota
Do you or someone you know suffer with rheumatoid arthritis?
Sarasota; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Sarasota; Lovelace Scientific Resources
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Sarasota ; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Sarasota ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Sarasota ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Sarasota ; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Sarasota ; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Sarasota ; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Sarasota ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Sarasota ; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Sarasota ; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Sarasota ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
South Miami; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
South Miami; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
South Miami; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
South Miami; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Tamarac; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Tamarac; West Broward Rheumatology Associates, Inc.
Do You Have Rheumatoid Arthritis?
Tamarac; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Tampa; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Tampa; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Tampa; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Tampa; Clinical Research of West Florida, Inc.
Bothered by Arthritis? Concerned About Heart Disease?
Tampa; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Tampa; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Tampa; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Tampa; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Tampa; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Tampa; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Tampa; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Center
Rheumatoid Arthritis Study CAIN457A2101
Vero Beach; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Vero Beach; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Vero Beach; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
West Palm Beach; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
West Palm Beach; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
West Palm Beach; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Zephyrhills; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Zephyrhills; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Zephyrhills; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Zephyrhills; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Georgia
Atlanta; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Atlanta; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Atlanta; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Atlanta; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Atlanta; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Atlanta; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Atlanta; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Atlanta; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Atlanta; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Atlanta; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Atlanta; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Blue Ridge; River Birch Research Alliance, LLC
A Randomized, Double-Blind, Parallel-Group Study to Evaluate the Safety and Efficacy of Tocilizumab (TCZ) versus Placebo in Combination with Methotrexate in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA)
Blue Ridge; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Bogart; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Cumming; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Cumming; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Decatur; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Decatur; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Fort Valley; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Macon ; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Macon ; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Marietta; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Marietta; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Rome; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Tifton; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Idaho
Boise; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Boise; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Boise; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Boise; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Boise; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Boise; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Boise; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Boise; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Boise; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Coeur d'Alene; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Coeur d'Alene; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Coeur D'Alene; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Coeur D'Alene; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Coeur D'Alene; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Coeur D'Alene; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Coeur D'Alene; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Coeur D'Alene; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Idaho Falls; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Idaho Falls; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Idaho Falls; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Idaho Falls; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Idaho Falls; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Idaho Falls; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Idaho Falls; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Meridan; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Meridan; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Meridan; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Meridan; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Meridan; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Meridan; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Meridan; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Meridan; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Meridan; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Meridan; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Nampa; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Nampa; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Illinois
Chicago; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Chicago; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Chicago; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Chicago; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Chicago; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Chicago; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Chicago; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Chicago; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Chicago; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Downers Grove; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Evanston; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Morton Grove; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Morton Grove; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Morton Grove; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Morton Grove; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Morton Grove; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Morton Grove; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Rock Island; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Rockford; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Rockford; Research Site:
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
Springfield; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Springfield; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Springfield; Research Center
Research study of Remicade in patients with Active Rheumatoid Arthritis who are not experiencing adequate relief to etanercept or adalimumab
Springfield; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Springfield; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Springfield; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Springfield; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Springfield; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
Springfield; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Springfield; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Springfield; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Springfield; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Vernon Hills; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Vernon Hills; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Vernon Hills; Research Site:
A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Vernon Hills; Research Site:
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Indiana
Evansville; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Evansville; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Indianapolis ; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Indianapolis ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Indianapolis ; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Indianapolis ; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Indianapolis ; Research Site:
A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
Indianapolis ; Research Site:
A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
Indianapolis ; Research Site:
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
Indianapolis ; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Indianapolis ; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Indianapolis ; Research Site:
A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
Indianapolis ; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Muncie; UCB Clinical Trial Call Center
Dosing Flexibility Study in Patients With RA
Munster; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Munster; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Munster; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Munster; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Munster; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
South Bend; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
South Bend; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
South Bend; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Various Cities; Research Site
If you have ever taken (or are currently taking) a biologic therapy and are still experiencing symptoms of rheumatoid arthritis, or if other therapy has not been effective for you, you may want to consider a CLINICAL INVESTIGATIONAL STUDY of an oral rheumatoid arthritis treatment with a new mode of action.
Iowa
Cedar Rapids; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Cedar Rapids; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Cedar Rapids; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Cedar Rapids; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Cedar Rapids; Research Site:
A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
Des Moines; Research Site:
An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
Des Moines; Research Site:
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
Kansas
Kansas City; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
Kansas City; Research Site:
A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
Kansas City; Research Site:
A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
Leawood; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Wichita; Wichita Clinic, PA
This is a phase 2 Rheumatoid Arthritis Study of patients on a stable dose of Methotrexate. Subjects will receive study medication.
Wichita; UCB Clinical Trial Call Center
Certolizumab Pegol for the Treatment of Patients With Active RA (SECOND STUDY) (Realistic)
Wichita; Research Site:
A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Wichita; Research Site:
A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
Wichita; Research Site:
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
Wichita; Wichita Clinic, PA
A Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients
Kentucky
Bowling Green; Research Site:
A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
